Table 1 Patient and treatment characteristics (n)
Gender | Time period | ||
|---|---|---|---|
Male | 45 | Before 2008 | 25 |
Female | 10 | After 2008 | 30 |
Age | PET-CT Staging | ||
Median | 75 yrs | Yes | 36 |
Range | 70–85 yrs | No | 19 |
Charlson Comorbidity Index | RT sequence | ||
≤1 | 40 | Definitive | 48 |
> 1 | 15 | Neoadjuvant | 7 |
Histology | RT technique | ||
Adenocarcinoma | 14 | 3D-CRT | 50 |
SCC | 41 | IMRT | 5 |
Localization | RT dose | ||
Cervical | 5 | median | 59.4Gy |
Upper thoracic | 12 | range | 10.8-66Gy |
Middle thoracic | 20 | ||
Lower thoracic | 18 | Chemotherapy | |
Yes | 47 | ||
Grading | full course | 31 | |
G1 | 1 | > 80% | 36 |
G2 | 30 | < 80% | 11 |
G3 | 24 | None | 8 |
T stage | N stage | ||
T1 | 1 | N0 | 23 |
T2 | 11 | N+ | 32 |
T3 | 32 | ||
T4 | 11 | ||